Home About Us Contact Us

 

Table of Content - Volume 10 Issue 2 - May 2018


 

Hypertensive complications in diabetes mellitus patients at tertiary health care centre

 

Lature L H1, S Anand2, Lature Mahalaxmi L3*

 

1Professor, 2Assistant Professor, Department of General Medicine, KBN Institute of Medical Sciences and Hospital, Kalaburgi – 585102.

3Assistant Professor, Department of Oral Medicine and Radiology medicine, ESIC Dental College of Dental Sciences and Hospital, Kalaburgi – 585102, INDIA.

Email: linarajlature@gmail.com , mahalaxmi.lature@gmail.com

 

REFERENCES

  1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
  2. Ramachandran A, Snehalatha C, Latha E, Satyavani K, Viswanathan V. Metabolic syndrome in Urban Asian Indian adults: A population study using modified ATP III criteria. Diab Prac Res Clin 2003; 60: 199-204.
  3. Sowers JR, Khoury S: Diabetes and hypertension: a review. Prim Care 1991, 18(3):509–524
  4. Sahay BK: API-ICP guidelines on DM. J Assoc Physicians India 2007, 55:1–50.
  5. Priya D, Dudhal K, Khakse GM, Meshram R, Hiwarkar PA, Wahab SN. Prevalence of hypertension among type 2 diabetes patients. Int J Sci Environ Technol 2013; 2: 1401-6.
  6. Ramachandran A, Snehalatha C, Vishwanath V. Burden of type 2 diabetes and its complications - The indian scenario. Curr Sci 2002; 83: 1471-6.
  7. Sechi LA, Bartoli E. Molecular mechanisms of insulin resistance in arterial hypertension. Blood Press Suppl 1996; 1: 47-54.
  8. Lender D, Arauz-Pacheco C, Breen L, Mora-Mora P, Ramirez LC, Raskin P. A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients. Am J Hypertens 1999; 12: 298- 303.
  9. Mogensen CE. Prevention and treatment of renal disease in insulin-dependent diabetes mellitus. Semin Nephrol 1990; 10: 260-73.
  10. Mykkänen L, Haffner SM, Kuusisto J, Pyorälä K, Laakso M. Microalbuminuria precedes the development of NIDDM. Diabetes 1994; 43: 552-7.
  11.  Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NR. Cardiovascular outcomes in framingham participants with diabetes: The importance of blood pressure. Hypertension 2011; 57: 891-7.
  12.  Ramirez LC, Arauz-Pacheco C, Lackner C, Albright G, Adams BV, Raskin P. Lipoprotein (a) levels in diabetes mellitus: Relationship to metabolic control. Ann Intern Med 1992; 117: 42-7.
  13.  Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: Pathway for lipid oxidation in vivo. Proc Natl Acad Sci U S A 1993; 90: 6434-8.
  14. Mohan V, Shanthirani S, Deepa R, et al. Intraurban differences in the prevalence of metabolic syndrome in southern India – The Chennai Urban Population Study (CUPS). Diab Med 2001; 18: 280-7.
  15. Maini MK. Patterns of renal disease in indigenous populations in India. Nephrology 1998; 4:S4-S7.
  16.  Premalatha G, Shanthirani S, Deepa R, Markovitz J, Mohan M. Prevalence of risk factors of peripheral vascular disease in a selected southern Indian population: the Chennai population study. Diab. Care 2000; 23: 1295-1300.
  17.  Ramachandran A, Snehalatha C, Latha E, Satyavani K, Vishwanathan M. Clustering of cardiovascular risk factors in urban Asian Indians. Diab Care 1998; 21:967-71.
Journal Menu MIJOMED Medpulse Manuscript Submission Subscription Aim & Scope Peer Review Process Publication Ethics & Malpractice Statement Open Access Statement Plagiarism Policy Editorial Board Indexing Current Issue Publication Charges Archives Authors Information Copyright & Licensing Privacy Statement Contact Us